79 related articles for article (PubMed ID: 31329736)
1. Corrigendum to "Hodgkin Lymphoma Cell Lines Are Characterized by a Specific miRNA Expression Profile."
Gibcus JH; Tan LP; Harms G; Schakel RN; de Jong D; Blokzijl T; Möller P; Poppema S; Kroesen BJ; van den Berg A
Neoplasia; 2018 Feb; 20(2):226. PubMed ID: 31329736
[TBL] [Abstract][Full Text] [Related]
2. Corrigendum to "PIAS1-FAK Interaction Promotes the Survival and Progression of Non-Small Cell Lung Cancer" [
Constanzo JD; Tang KJ; Rindhe S; Melegari M; Liu H; Tang X; Rodriguez-Canales J; Wistuba I; Scaglioni PP
Neoplasia; 2016 Jul; 18(7):457. PubMed ID: 31265543
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum to "Visualization of the Biological Behavior of Tumor-Associated Macrophages in Living Mice with Colon Cancer Using Multimodal Optical Reporter Gene Imaging" [
Choi YJ; Oh SG; Singh TD; Ha JH; Kim DW; Lee S; Jeong S; Ahn BC; Lee J; Jeon YH
Neoplasia; 2016 Jul; 18(7):458. PubMed ID: 31265544
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum to: miRNA expression profile of retinal pigment epithelial cells under oxidative stress conditions.
Donato L; Bramanti P; Scimone C; Rinaldi C; Giorgianni F; Beranova-Giorgianni S; Koirala D; D'Angelo R; Sidoti A
FEBS Open Bio; 2018 Nov; 8(11):1884. PubMed ID: 30410868
[TBL] [Abstract][Full Text] [Related]
5. Corrigendum: Evaluation and management of systemic corticosteroids-induced ocular hypertension in children with non-Hodgkin lymphoma.
Chang Y; Zhang Y; Cui Z; Jin X; Zhao Y; Liang L; Chang J
Front Pediatr; 2022; 10():1034111. PubMed ID: 36405819
[TBL] [Abstract][Full Text] [Related]
6. Corrigendum to: ``The immune landscape of chondrosarcoma reveals an immunosuppressive environment in the dedifferentiated subtypes and exposes CSFR1+ macrophages as a promising therapeutic target.'' J Bone Oncol. 2020 Feb; 20: 100271.
Richert I; Gomez-Brouchet A; Bouvier C; Du Bouexic De Pinieux G; KaranianM A; Blay JY; Dutour A
J Bone Oncol; 2020 Jun; 22():100287. PubMed ID: 32274326
[TBL] [Abstract][Full Text] [Related]
7. Micro-RNA (miRNA) profile in Hodgkin lymphoma: association between clinical and pathological variables.
Paydas S; Acikalin A; Ergin M; Celik H; Yavuz B; Tanriverdi K
Med Oncol; 2016 Apr; 33(4):34. PubMed ID: 26951445
[TBL] [Abstract][Full Text] [Related]
8. Corrigendum to "Expression of miRNA-122 Induced by Liver Toxicants in Zebrafish".
Nam HS; Hwang KS; Jeong YM; Ryu JI; Choi TY; Bae MA; Son WC; You KH; Son HY; Kim CH
Biomed Res Int; 2017; 2017():1347806. PubMed ID: 28831391
[TBL] [Abstract][Full Text] [Related]
9. Dysregulated MicroRNA Expression Profiles and Potential Cellular, Circulating and Polymorphic Biomarkers in Non-Hodgkin Lymphoma.
Bradshaw G; Sutherland HG; Haupt LM; Griffiths LR
Genes (Basel); 2016 Dec; 7(12):. PubMed ID: 27999330
[TBL] [Abstract][Full Text] [Related]
10. Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77+ B-cells reveals a distinct subset of differentially expressed miRNAs.
Van Vlierberghe P; De Weer A; Mestdagh P; Feys T; De Preter K; De Paepe P; Lambein K; Vandesompele J; Van Roy N; Verhasselt B; Poppe B; Speleman F
Br J Haematol; 2009 Dec; 147(5):686-90. PubMed ID: 19775296
[TBL] [Abstract][Full Text] [Related]
11. Corrigendum: Microarray profiling of miRNA and mRNA expression in Rag2 knockout and wild-type mouse spleens.
Reza AMMT; Cho SK; Choi YJ; Hong K; Kim JH
Sci Data; 2018 Jul; 5():180152. PubMed ID: 30063228
[TBL] [Abstract][Full Text] [Related]
12. "Intrafollicular neoplasia" of nodular lymphocyte predominant Hodgkin lymphoma: description of a hypothetic early step of the disease.
Carbone A; Gloghini A
Hum Pathol; 2012 May; 43(5):619-28. PubMed ID: 22209342
[TBL] [Abstract][Full Text] [Related]
13. Corrigendum to "Quantitative Detection of miRNA-21 Expression in Tumor Cells and Tissues Based on Molecular Beacon".
Liu Q; Fan J; Zhou C; Wang L; Zhao B; Zhang H; Liu B; Tong C
Int J Anal Chem; 2020; 2020():1515794. PubMed ID: 32411247
[TBL] [Abstract][Full Text] [Related]
14. Corrigendum: miARma-Seq: a comprehensive tool for miRNA, mRNA and circRNA analysis.
Andrés-León E; Núñez-Torres R; Rojas AM
Sci Rep; 2018 Jan; 8():46928. PubMed ID: 29308784
[TBL] [Abstract][Full Text] [Related]
15. Corrigendum #2 to "Quantitative Detection of miRNA-21 Expression in Tumor Cells and Tissues Based on Molecular Beacon".
Liu Q; Fan J; Zhou C; Wang L; Zhao B; Zhang H; Liu B; Tong C
Int J Anal Chem; 2021; 2021():8406935. PubMed ID: 33510790
[TBL] [Abstract][Full Text] [Related]
16. Corrigendum: Microenvironment Cell Contribution to Lymphoma Immunity.
Kumar D; Xu ML
Front Oncol; 2018; 8():522. PubMed ID: 30460201
[TBL] [Abstract][Full Text] [Related]
17. Corrigendum: Purification and Identification of miRNA Target Sites in Genome Using DNA Affinity Precipitation.
Xun Y; Tang Y; Hu L; Xiao H; Long S; Gong M; Wei C; Wei K; Xiang S
Front Genet; 2020; 11():909. PubMed ID: 32973874
[TBL] [Abstract][Full Text] [Related]
18. MiRNA profiling in B non-Hodgkin lymphoma: a MYC-related miRNA profile characterizes Burkitt lymphoma.
Robertus JL; Kluiver J; Weggemans C; Harms G; Reijmers RM; Swart Y; Kok K; Rosati S; Schuuring E; van Imhoff G; Pals ST; Kluin P; van den Berg A
Br J Haematol; 2010 Jun; 149(6):896-9. PubMed ID: 20331457
[No Abstract] [Full Text] [Related]
19. MicroRNA High Throughput Loss-of-Function Screening Reveals an Oncogenic Role for miR-21-5p in Hodgkin Lymphoma.
Yuan Y; Niu F; Nolte IM; Koerts J; de Jong D; Rutgers B; Osinga J; Azkanaz M; Terpstra M; Bystrykh L; Diepstra A; Visser L; Dzikiewicz-Krawczyk A; Kok K; Kluiver J; van den Berg A
Cell Physiol Biochem; 2018; 49(1):144-159. PubMed ID: 30184526
[TBL] [Abstract][Full Text] [Related]
20. Corrigendum: Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines.
Harenza JL; Diamond MA; Adams RN; Song MM; Davidson HL; Hart LS; Dent MH; Fortina P; Reynolds CP; Maris JM
Sci Data; 2017 Dec; 4():170183. PubMed ID: 29206221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
